The Circle of Kindness Foundation is currently purchasing medicines for the first quarter of 2022 in order to prevent a shortage of drugs, as Alexander Rumyantsev, the Chairman of the Expert Council of the Foundation, president of the Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology, Chief pediatric hematologist of the Ministry of Health of Russia stated for the First channel.
“We are making purchases, including those for the first quarter of next year, in order to avoid a shortage that often occurs in the first months of the year,” he said. Rumyantsev noted that the Foundation had already purchased 12 medicines worth 15 billion rubles.
In addition, according to Rumyantsev, 19 billion rubles “have already been reserved in connection with drug supply contracts.”
“Two drugs against spinal muscular atrophy have already been fully delivered to the consumer,” he added.
Earlier, the Circle of Kindness Foundation signed contracts for the supply of Qarziba (dinutuximab beta) and Zolgensma (onasemnogene abeparvovec), which are not registered in Russia.
